New cancer vaccine method boosts potency and scope
Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for melanoma. Since then, many therapeutic - as opposed to preventive - cancer vaccines have been in development, but none approved. One hurdle is the difficulty in finding antigens in tumors that look foreign enough to trigger an immune response.
Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for melanoma. Since then, many therapeutic - as opposed to preventive - cancer vaccines have been in development, but none approved. One hurdle is the difficulty in finding antigens in tumors that look foreign enough to trigger an immune response.
